Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571083
Horizontal Plyometric Training and Sprint Mechanics in Early-Adolescent Track-and-Field AthletesFederal University of VicosaCompletedNot Applicable
NCT07571083Completed
Not Applicable
Horizontal Plyometric Training and Sprint Mechanics in Early-Adolescent Track-an...Federal University of Vic...
NCT07570290
Comparison of Artificial Intelligence and Clinicians With Different Experience Levels in Assessing Gingival PhenotypeOndokuz Mayıs UniversityNot Yet Recruiting
NCT07570290Not Yet Recruiting
—
Comparison of Artificial Intelligence and Clinicians With Different Experience L...Ondokuz Mayıs University
NCT07569601
The Effect of Heat Pads and Foam Rolling on Strength in Athletes.University of RedlandsActive Not RecruitingNot Applicable
NCT07569601Active Not Recruiting
Not Applicable
The Effect of Heat Pads and Foam Rolling on Strength in Athletes.University of Redlands
NCT07571291
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSISFondazione IRCCS Policlinico San Matteo di PaviaActive Not Recruiting
NCT07571291Active Not Recruiting
—
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF I...Fondazione IRCCS Policlin...
NCT07571252
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto RicoNot Yet RecruitingPhase 4
NCT07571252Not Yet Recruiting
Phase 4
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto Rico
NCT07569367
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumBioSensicsNot Yet Recruiting
NCT07569367Not Yet Recruiting
—
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotem...BioSensics
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07571122
Cognitive Training for Pain , Balance and Foot Function in Plantar FasciitisBeni-Suef UniversityRecruitingNot Applicable
NCT07571122Recruiting
Not Applicable
Cognitive Training for Pain , Balance and Foot Function in Plantar FasciitisBeni-Suef University
NCT07571031
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell CarcinomaFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07571031Not Yet Recruiting
—
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of...Fondazione Policlinico Un...
NCT07568782
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.Lille UniversityNot Yet Recruiting
NCT07568782Not Yet Recruiting
—
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Im...Lille University
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569042
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed GlioblastomaNovelwise Pharmaceutical CorporationRecruitingPhase 1
NCT07569042Recruiting
Phase 1
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Ne...Novelwise Pharmaceutical...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571005
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNovo Nordisk A/SNot Yet RecruitingPhase 3
NCT07571005Not Yet Recruiting
Phase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...Novo Nordisk A/S
NCT07569484
Effectiveness of Dry Needling in Athletes With Chronic Hamstring StrainCairo UniversityNot Yet RecruitingNot Applicable
NCT07569484Not Yet Recruiting
Not Applicable
Effectiveness of Dry Needling in Athletes With Chronic Hamstring StrainCairo University
NCT07570524
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene MarquisNot Yet Recruiting
NCT07570524Not Yet Recruiting
—
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene Marquis
NCT07570368
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast CancerUniversitas AirlanggaNot Yet RecruitingNot Applicable
NCT07570368Not Yet Recruiting
Not Applicable
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to E...Universitas Airlangga
NCT07569523
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNot Yet Recruiting
NCT07569523Not Yet Recruiting
—
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Rece...
NCT07569536
Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic ShockCentre Hospitalier Universitaire DijonNot Yet RecruitingPhase 3
NCT07569536Not Yet Recruiting
Phase 3
Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in...Centre Hospitalier Univer...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Active, not recruiting2 (10%)
Completed1 (5%)
Not Specified7 (35%)
not_applicable6 (30%)
Phase 22 (10%)
Phase 12 (10%)
Phase 32 (10%)
Phase 41 (5%)